Impact of systemic hypoxemia on cancer aggressiveness and circulating vascular endothelial growth factors A and C in gastroesophaeal cancer patients with chronic respiratory insufficiency

Experimental Oncology

Volumn 29, Issue 3, 2007, Pages 236-242

  Krzystek Korpacka, M ^a   Matusiewicz, M ^a   Diakowska, D ^a   Grabowski, K ^a   Blachut, K ^b   Kustrzeba Wojcicka, I ^a   Gamian, A ^a,c  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Department of Gastroenterology and Hepatology   (Poland)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Angiogenesis; COPD; Esophagogastric cancer; Hypoxemia; Respiratory insufficiency; VEGF A; VEGF C

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ESOPHAGOGASTRIC CANCER; FEMALE; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE;

AGED; ANOXIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RESPIRATORY INSUFFICIENCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 36749100949     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Brahimi-Horn Ch, Pouyssegur J. The role of the hypoxia-inducible factor in tumor metabolism, growth and invasion. Bull Cancer 2006; 93: E73-80.
2. Ding MX, Lin XQ, Fu XY, Zhang N, Li JC. Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma. World J Gastroenterol 2006; 12: 4582-5.
3. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-52.
4. Gunga HC, Kirsch K, Rocker L, Behn C, Koralewski E, Davila EH, Estrada MI, Johannes B, Wittels P, Jelkmann W. Vascular endothelial growth factor in exercising humans under different environmental conditions. Eur J Appl Physiol Occup Physiol 1999; 79: 484-90.
5. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001; 93: 266-76.
6. Imagawa S, Yamagouchi Y, Higuchi M, Neichi T, Hasegawa Y, Mukai HY, Suzuki N, Yamamoto M, Nagasawa T. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 2001; 98: 1255-7.
7. Katsuta M, Miyashita M, Makino H, Nomura T, Shinji S, Yamashita K, Tajiri T, Kudo M, Ishiwata T, Naito Z. Correlation of hypoxia inducible factor-1α with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol 2005; 78: 123-30.
8. Kierszniewska-Stepien D, Pietras T, Gorski P, Stepien H. Serum vascular endothelial growth factor and its receptor level in patients with chronic obstructive pulmonary disease. Eur Cytokine Netw 2006; 17: 75-9.
9. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Banas T. Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC). Cancer Lett 2007; 249: 171-7.
10. Lavie L, Kraiczi H, Hefetz A, Ghandour H, Perelman A, Hedner J, Lavie P. Plasma vascular endothelial growth factor on sleep apnea syndrome. Am J Respir Crit Care Med 2002; 165: 1624-8.
11. Lee SJ, Lee KS, Yim YJ, Kim TS, Shim YM, Kim K. Recurrence of squamous cell carcinoma of the oesophagus after curative surgery: rates and patterns on imaging studies correlated with tumour location and pathological stage. Clin Radiol 2005; 60: 547-54.
12. Matsumoto M, Natsugoe S, Okumura H, Arima H, Yanagita S, Uchikado Y, Yokomakura N, Setoyama T, Ishigami S, Takao S, Aikou T. Overexpression of vascular endothelial growth factor-C correlates with lymph node micrometastasis in submucosal esophageal cancer. J Gastrointest Surg 2006; 10: 1016-22.
13. Matsuyama W, Hashiguchi T, Mizoguchi A, Iwami F, Kawabata M, Arimura K, Osame M. Serum levels of vascular endothelial growth factor dependent on the stage preogression of lung cancer. Chest 2000; 118: 948-51.
14. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Hackenberg C, Schweiger U, Born J, Fehm HL, Peters A. Acute hypoxia decreases plasma VEGF concentration in healthy humans. Am J Physiol Endocrinol Metab 2006; 290: E434-9.
15. Ono T, Miki Ch. Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma. Am J Gastroenterol 2000; 95: 1062-7.
16. Papaioannou AI, Kostikas K, Kollia P, Gourgoulianis KI. Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Respiratory Res 2006; 7: 128.
17. Reilly JJ, Silverman EK, Shapiro SD. Chronic obstructive pulmonary disease. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Isselbacher KI, eds. Harrison's Principles of Internal Medicine. Sixteenth Edition. McGrow-Hill Medical Publishing Division, 2005: 1547-54.
18. Schoppmann SF, Fenzl A, Schindl M, Bachleitner-Hofmann T, Nagy K, Gnant M, Horvat R, Jakesz R, Birner P. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat 2006; 99: 135-41.
19. Schulz R, Hummel Ch, Heinemann S, Seeger W, Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 2002; 165: 67-70.
20. Sobin LH, Wittekind Ch. TNM Classification of Malignant Tumors. 6th ed. New Jersey: Jon Wiley & Sons, Hoeboken, 2002.
21. Takahasi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci 2005; 109: 227-41.
22. Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, Hill RP, Koch CJ, Krishna MC, Krohn KA, Lewis JS, Mason RP, Melillo G, Padhani AR, Powis G, Rajendran JG, Reba R, Robinson SP, Semenza GL, Swartz HM, Vaupel P, Yang D, Croft B, Hoffman J, Liu G, Stone H, Sullivan D. Hypoxia: importance intumorbiology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 2006; 82: 699-757.
23. Teramoto S, Kume H, Yamamoto H, Ishii T, Miyashita A, Matsuse T, Akishita M, Toba K, Ouchi Y. Effects of oxygen administration on the circulating vascular ensothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome. Internal Med 2003; 42: 681-5.
24. Tissot van Patot MC, Leadbetter G, Keyes LF, Bendrick-Peart J, Beckey VE, Christians U, Hackett P. Greater free plasma VEGF and lower soluble VEGF receptor-1 acute mountain sickness. J Appl Physiol 2005; 98: 1626-9.
25. Valipour A, Litschauer B, Mittermayer F, Rauscher H, Burghuber OCh, Woltz M. Circulating plasma levels of vascular endothelial growth factor in patients with sleep disordered breathing. Respiratory medicine 2004; 98: 1180-6.
26. Vallbohmer D, Lenz H-J. Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus 2006; 19: 425-32.
27. Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 2004; 9: 4-9.
28. Vaupel P, Mayer A. Hypoxia and anemia: effects on tumor biology and treatment resistance. Transfus Clin Biol 2005; 12: 5-10.
29. Walter R, Maggiorini M, Scherrer U, Contesse J, Reinhart WH. Effect of high-altitude exposure on vascular endothelial growth factor levels in man. Eur J Appl Physiol 2001; 85: 113-7.